Document Classification

Section Type: RESULTS

Text: RVEDV (184. 5 + / -56. 4 ml vs. 179. 6 + / -66. 4 ml, p = 0. 64) and RVESV (109. 5 + / -19. 4 ml vs. 111. 8 + / -30. 1, p = 0. 74) remained unchanged in the Ramipril group from baseline to 1 year as well as in the placebo group (228. 1 + / -89. 2 ml vs. 204. 5 + / -50. 4 ml, p = 0. 42 and 117. 5 + / -36. 9 ml vs. 117. 4 + / -26. 2 ml, p = 0. 99, respectively).